Small Molecules

31 Jan 2007 YM Biosciences Announces Termination Of The Tesmilifene Phase III Pivotal Trial In Advanced Breast Cancer
31 Jan 2007 FDA approves Neuren's phase 3 Glypromate trial
31 Jan 2007 AVANIR Receives FDA Approvable Letter for New Formulation of Currently Marketed Antipsychotic Drug FazaClo
31 Jan 2007 Santhera Updates Development Strategy for SNT-MC17/idebenone in Friedreich's Ataxia in the US
30 Jan 2007 Tarceva : European approval for pancreatic cancer treatment
30 Jan 2007 Sunesis Pharmaceuticals Reports Positive Initial Results From Phase 2 Small Cell Lung Cancer Trial With SNS-595
30 Jan 2007 Inflazyme Pharmaceuticals Announces Preliminary Outcome of the Phase 2b CAPSICS Asthma Trial
30 Jan 2007 Pharmion Corporation Announces FDA Approval of Vidaza NDA Supplement for IV Administration
30 Jan 2007 New indication for YAZ(R) approved in the U.S.
30 Jan 2007 Threshold Pharmaceuticals Initiates Phase 2 Clinical Trial Evaluating Glufosfamide In Patients With Platinum-Resistant Ovarian Cancer
27 Jan 2007 Oral formulation of Fludara(R) approved in Japan
27 Jan 2007 Antiviral Agent Copegus(R) Tablet 200 mg Received Approval as a Combination Therapy with Chronic Hepatitis C Treatment Drug Pegasys
27 Jan 2007 Approval for Candin Antifungal Agent Funguard for Prophylaxis of Aspergillus and Candida infections in patients undergoing HSCT and Immunosuppressant Prograf for Lupus Nephritis in Japan
27 Jan 2007 AEterna Zentaris Discloses New In Vivo Data for ZEN-012 at the 7th Joint Conference of the AACR and JCA
26 Jan 2007 Biocryst Initiates Phase II Influenza Clinical Trial To Evaluate Peramivir
26 Jan 2007 European Medicines Agency Adopts Positive Opinion Recommending Approval of Xyrem(R) for the Treatment of Narcolepsy with Cataplexy in Adult Patients
26 Jan 2007 JANUVIA(TM), First in New Class of Oral Treatments Known as DPP-4 Inhibitors, Recommended for Approval for the Treatment of Type 2 Diabetes in the European Union
26 Jan 2007 Toyama Chemical Submits IND for Its Anti-Influenza Compound “T-705”
26 Jan 2007 Royalmount Pharma and US National Cancer Institute Commence Patient Enrolment in a Phase I Clinical Trial With RM1812
26 Jan 2007 Nippon Shinyaku, Apogepha Terminate Development of NS-8, for the Treatment of Overactive Bladder
25 Jan 2007 Merck Serono Has Initiated The Onward Study To Evaluate Oral Cladribine As Add-On Treatment For Multiple Sclerosis
25 Jan 2007 Lexicon Genetics Initiates Clinical Trials of LX1031 for Irritable Bowel Syndrome
25 Jan 2007 Obecure Recruits First Patient in Phase II Obesity Study
24 Jan 2007 Wyeth Receives Approvable Letter From FDA for Pristiq (Desvenlafaxine Succinate) for the Treatment of Major Depressive Disorder
24 Jan 2007 MediGene Initiates a Clinical Phase IIa Trial of RhuDex(R) in Rheumatoid Arthritis

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up